Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.
about
Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous SystemTransplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injuryAstrocytes conspire with neurons during progression of neurological diseaseGlia: an emerging target for neurological disease therapyInduced pluripotent stem cells from ALS patients for disease modelingTherapeutic neuroprotective agents for amyotrophic lateral sclerosisTherapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cellsNeuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration.Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in ratsAdeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.Fast skeletal muscle troponin activator tirasemtiv increases muscle function and performance in the B6SJL-SOD1G93A ALS mouse modelHuman glial progenitor engraftment and gene expression is independent of the ALS environmentA Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood PlasmaNecroptosis drives motor neuron death in models of both sporadic and familial ALS.Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS miceEnhanced GLT-1 mediated glutamate uptake and migration of primary astrocytes directed by fibronectin-coated electrospun poly-L-lactic acid fibers.Low-frequency magnetic fields do not aggravate disease in mouse models of Alzheimer's disease and amyotrophic lateral sclerosis.Human-derived neural progenitors functionally replace astrocytes in adult mice.Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosisWnt Signaling Alteration in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Mice: Special Focus on Frizzled-5 Cellular Expression PatternThe Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis.Stem cell therapy for amyotrophic lateral sclerosisEntorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosisAmyotrophic lateral sclerosis and organ donation: is there risk of disease transmission?Intricate interplay between astrocytes and motor neurons in ALS.Genome-Scale Mapping of MicroRNA Signatures in Human Embryonic Stem Cell Neurogenesis.An Engraftable Human Embryonic Stem Cell Neuronal Lineage-Specific Derivative Retains Embryonic Chromatin Plasticity for Scale-Up CNS RegenerationReverse engineering human neurodegenerative disease using pluripotent stem cell technology.Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosisPhenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALSWidespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosisCan regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?Astrocyte signaling and neurodegeneration: new insights into CNS disorders.The multifaceted role of glial cells in amyotrophic lateral sclerosis.Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.Amyotrophic lateral sclerosis and skeletal muscle: an update.
P2860
Q26766006-1793E411-DBB5-4B08-AACA-7D0F5EAEF78DQ26825854-1CCB0433-9313-4D4B-BA52-B0D44A26DA06Q26852070-D64E0BE9-932B-4992-90F8-DF0245F17991Q27000259-00E0508A-0322-406E-A71A-98B92963C1CCQ27000647-AAE2C0EF-BAA8-420A-8FEF-F692D96A1909Q27015029-8ACC2502-1803-40EE-97F5-A65F13698742Q27687180-E3212E32-0446-4EF7-BF10-B8BF2BC26721Q28543975-F0578353-2216-44D0-A7E3-A06063A15783Q30523191-CA92ECA9-62C3-42BD-9143-C9BE93207A3EQ30574944-E5A5D1F0-CD36-43A5-BD9E-84AF38A5DE61Q30575773-496B64CD-C988-4DD6-B97E-6A6665D989F3Q30843477-F0686B75-FC94-43D1-A73E-BABFEC1FD953Q33578284-3358EBEC-3D16-41CB-B730-CD8CF01B9D4EQ33620690-2402F0C4-D154-4E68-966C-1E6E42F6C513Q33799866-DA5787B1-EC2E-4948-B268-3E11CB1F422EQ34039826-C3B8909A-6F71-4573-9E56-B9C55DF6F0B6Q34246088-CD5ABE22-CC39-4433-B1EE-D0C8FDB0668CQ34280092-95FCBE96-F3CB-4225-A32F-ADCF391B8BC2Q35123619-A1F0828B-1133-451A-9102-6BFD82734C29Q35183893-1C87374A-349F-48AE-B7E9-4E54CE089A75Q35529701-1D40F6FA-5741-4BC0-96DE-CF763C618627Q36021420-402100F9-C9B8-486D-9880-85CAB5345D26Q36284525-F2F6C183-3DCC-4CB2-9FDD-83C0643A11EDQ36301821-F0820368-E14A-4F6B-B281-A26B340B8F17Q36317708-959A7CE6-8C1A-464A-83B5-745338577932Q36466787-92B63249-C28C-4881-9615-9482932999CEQ36601641-89A6DE08-45E6-4533-AB4B-84168D8D7482Q36637458-AC93CE41-8884-4C5C-B98A-5ADA1589BC8FQ36720903-DD2C1C48-667C-412F-8D71-50F6A150FC1BQ36720917-384CFCDE-3D40-4BD4-92DE-17C6277DB917Q36734551-AF17FAEA-F6C5-4BAB-A5AE-C764ABB5503CQ36890607-AAE43AD4-B0D2-46FA-B71A-B2309CBC1FEEQ37412113-1F966D8B-9093-4995-8349-556D0E7D0C43Q37463967-B13E7C68-3B9B-4864-A5C1-468E7B73328AQ37640081-009ECBA0-3E2C-4F84-856C-20CA0C29291DQ38006463-AE3D972C-C009-4CFA-8565-BBCB0B3D6889Q38055136-20EE7EC5-8E47-4438-945D-A5776CFEC5D3Q38126396-4AEF44B9-774A-4797-A504-171302F8CC69Q38150127-696A1B57-030E-4267-AEC4-CCAFB4A1393AQ38160421-267319D1-2AF6-4F73-A971-6C3062BA9972
P2860
Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@ast
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@en
type
label
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@ast
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@en
prefLabel
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@ast
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@en
P2093
P2860
P356
P1476
Astrocytes carrying the supero ...... r neuron degeneration in vivo.
@en
P2093
Angelo C Lepore
Colin O'Banion
Nicholas J Maragakis
Sarah E Kraig
Sophia T Papadeas
P2860
P304
17803-17808
P356
10.1073/PNAS.1103141108
P407
P577
2011-10-03T00:00:00Z